Businesses interested in operating as medical cannabis dispensaries in the U.S. can begin submitting applications starting Wednesday, April 29, following a directive from President Donald Trump to change how marijuana is classified under federal law. The update was announced through a notice published on the website of the Drug Enforcement Administration (DEA).
According to the agency, its online system for medical marijuana registration will open at 9 a.m. Eastern Time. The rollout comes just days after the Justice Department revealed plans to ease certain federal limits on cannabis-related products and accelerate efforts to place marijuana in a less restrictive category.
Companies applying for approval will need to meet several requirements. The DEA has set an annual application fee of $794. In addition, applicants must respond to detailed questions about their compliance history. This includes disclosing whether they have ever given up a professional license issued by a state authority or had a registration related to controlled substances suspended or revoked.
The application process also requires businesses to outline the security arrangements at any proposed dispensary site. These measures are intended to ensure that cannabis products are stored and distributed in line with federal expectations, particularly as oversight evolves under the new classification approach.
Cannabis remains the most commonly used illegal substance both globally and within the U.S. Data from the Centers for Disease Control and Prevention indicates that close to 20% of Americans report using marijuana at least once each year. Despite its widespread use, the drug has historically been subject to strict enforcement, leading to millions of arrests for possession over the decades.
At the same time, the legal cannabis market has expanded rapidly. A growing number of companies are involved in producing and selling marijuana-related goods in states where such activities are permitted under local law. This has created a complex landscape in which state-level legalization coexists with federal restrictions.
The decision to reclassify marijuana signals a shift in federal policy, but it does not amount to full legalization nationwide. Cannabis will still be regulated, and its legal status will continue to vary depending on jurisdiction. Federal authorities are expected to maintain oversight, even as rules are adjusted to reflect changing attitudes and increased medical use.
As applications begin, regulators and companies alike will be watching closely to see how the new system functions in practice and what it may signal for the future of cannabis policy in the U.S.
While this recent regulatory change may not have been what marijuana companies like TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) had hoped for, it is nonetheless a starting point that other reforms can be built upon.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
CannabisNewsWire 